Page last updated: 2024-08-22

didodecyldimethylammonium and Cystic Fibrosis

didodecyldimethylammonium has been researched along with Cystic Fibrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colosimo, A; Dallapiccola, B; Gagné, L; Goncz, KK; Gruenert, DC; Hong, K; Novelli, G; Papahadjopoulos, D; Sawa, T; Schreier, H; Wiener-Kronish, J; Xu, Z	1

Other Studies

1 other study(ies) available for didodecyldimethylammonium and Cystic Fibrosis

Article	Year
Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR. Gene therapy, 2001, Volume: 8, Issue:12 Topics: Animals; Cation Exchange Resins; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Deletion; Gene Expression; Genetic Therapy; Genetic Vectors; Lipids; Liposomes; Lung; Mice; Mice, Transgenic; Quaternary Ammonium Compounds; RNA, Messenger; Transfection; Virosomes	2001

Article

Year

Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR.

Gene therapy, 2001, Volume: 8, Issue:12

Topics: Animals; Cation Exchange Resins; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Deletion; Gene Expression; Genetic Therapy; Genetic Vectors; Lipids; Liposomes; Lung; Mice; Mice, Transgenic; Quaternary Ammonium Compounds; RNA, Messenger; Transfection; Virosomes

2001